PL145221B1 - Method of obtaining novel derivatives of tetracyclic spiro glyclylurea - Google Patents

Method of obtaining novel derivatives of tetracyclic spiro glyclylurea Download PDF

Info

Publication number
PL145221B1
PL145221B1 PL1985254960A PL25496085A PL145221B1 PL 145221 B1 PL145221 B1 PL 145221B1 PL 1985254960 A PL1985254960 A PL 1985254960A PL 25496085 A PL25496085 A PL 25496085A PL 145221 B1 PL145221 B1 PL 145221B1
Authority
PL
Poland
Prior art keywords
formula
acid
hydrogen
chlorine
group
Prior art date
Application number
PL1985254960A
Other languages
English (en)
Polish (pl)
Other versions
PL254960A1 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL254960A1 publication Critical patent/PL254960A1/xx
Publication of PL145221B1 publication Critical patent/PL145221B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/16—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PL1985254960A 1984-08-14 1985-08-13 Method of obtaining novel derivatives of tetracyclic spiro glyclylurea PL145221B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1984/001290 WO1986001107A1 (en) 1984-08-14 1984-08-14 Tetracyclic spiro-hydantoin aldose reductase inhibitors, compositions and methods of making

Publications (2)

Publication Number Publication Date
PL254960A1 PL254960A1 (en) 1987-01-12
PL145221B1 true PL145221B1 (en) 1988-08-31

Family

ID=22182231

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1985261413A PL147875B1 (en) 1984-08-14 1985-08-13 Method of obtaining derivatives of tetracyclic spirolohydantoine
PL1985254960A PL145221B1 (en) 1984-08-14 1985-08-13 Method of obtaining novel derivatives of tetracyclic spiro glyclylurea

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL1985261413A PL147875B1 (en) 1984-08-14 1985-08-13 Method of obtaining derivatives of tetracyclic spirolohydantoine

Country Status (24)

Country Link
US (1) US4656169A (es)
EP (1) EP0173497B1 (es)
JP (1) JPS6147486A (es)
KR (1) KR870000624B1 (es)
AT (1) ATE46162T1 (es)
AU (1) AU553699B2 (es)
CA (1) CA1255304A (es)
DD (1) DD236529A5 (es)
DE (1) DE3572818D1 (es)
DK (1) DK366685A (es)
ES (2) ES8704495A1 (es)
FI (1) FI82695C (es)
GR (1) GR851968B (es)
IE (1) IE58123B1 (es)
IL (1) IL76076A0 (es)
IN (2) IN166581B (es)
NO (1) NO164101C (es)
NZ (1) NZ213085A (es)
PH (1) PH22910A (es)
PL (2) PL147875B1 (es)
PT (1) PT80940B (es)
WO (1) WO1986001107A1 (es)
YU (1) YU44894B (es)
ZA (1) ZA856102B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004751A (en) * 1987-08-28 1991-04-02 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
US5202339A (en) * 1987-08-28 1993-04-13 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
AU623676B2 (en) * 1988-08-24 1992-05-21 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
TW202450B (es) * 1991-06-26 1993-03-21 Dainippon Pharmaceutical Co

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4193996A (en) * 1979-04-04 1980-03-18 Pfizer Inc. Spiro-quinolone hydantoins
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives

Also Published As

Publication number Publication date
YU129085A (en) 1988-04-30
PH22910A (en) 1989-01-24
GR851968B (es) 1985-12-13
KR870000624B1 (ko) 1987-03-26
JPH0339512B2 (es) 1991-06-14
DE3572818D1 (en) 1989-10-12
AU4612685A (en) 1986-02-20
ES546093A0 (es) 1987-04-01
NO164101C (no) 1990-08-29
NO164101B (no) 1990-05-21
FI82695C (fi) 1991-04-10
DK366685D0 (da) 1985-08-13
PL261413A1 (en) 1988-01-21
IE851991L (en) 1986-02-14
ATE46162T1 (de) 1989-09-15
IN166581B (es) 1990-06-09
YU44894B (en) 1991-04-30
FI82695B (fi) 1990-12-31
DK366685A (da) 1986-02-15
IN166590B (es) 1990-06-09
NO861425L (no) 1986-04-11
IL76076A0 (en) 1985-12-31
NZ213085A (en) 1988-03-30
PT80940A (en) 1985-09-01
PL254960A1 (en) 1987-01-12
US4656169A (en) 1987-04-07
EP0173497A1 (en) 1986-03-05
ES8801831A1 (es) 1988-02-16
AU553699B2 (en) 1986-07-24
IE58123B1 (en) 1993-07-14
ZA856102B (en) 1987-03-25
DD236529A5 (de) 1986-06-11
CA1255304A (en) 1989-06-06
PL147875B1 (en) 1989-08-31
JPS6147486A (ja) 1986-03-07
EP0173497B1 (en) 1989-09-06
FI861544A (fi) 1986-04-11
WO1986001107A1 (en) 1986-02-27
PT80940B (pt) 1987-12-30
ES551963A0 (es) 1988-02-16
ES8704495A1 (es) 1987-04-01
FI861544A0 (fi) 1986-04-11
KR860001811A (ko) 1986-03-22

Similar Documents

Publication Publication Date Title
CA1202637A (en) Antifibrinolytically active compounds
FI62838B (fi) Foerfarande foer framstaellning av den nya farmaceutiskt anvaendbara hoegerroterande isomeren av en asymmetriskt spiro-hydantoinfoerening
EP0859610B1 (en) Ibogamine congeners
IE811522L (en) Phenylethanolamines
US5236940A (en) Pharmaceutical compositions, 2-benzothiazolamine derivatives, and their preparation
AU6307590A (en) Biphenylmethane derivative and pharmacological use
GR3024896T3 (en) Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses
JPS607997B2 (ja) ヒダントイン誘導体治療剤
WO2006089130A1 (en) Kappa opioid receptor ligands
US4798843A (en) 2-mercaproimidazole dopamine-β-hydroxylase inhibitors
RU1830063C (ru) Способ получени замещенных 1-(1Н-имидазол-4-ил)-алкилбензамидов или их солей присоединени с кислотами нетоксичными и фармацевтически приемлемыми
US4595699A (en) Immune system regulation using novel phenylalkanoic acid derivative
US4134991A (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
PL145221B1 (en) Method of obtaining novel derivatives of tetracyclic spiro glyclylurea
CA1182472A (en) N-[(2-naphthalenyl)thioxomethyl]glycine derivatives
CA1153766A (en) Thioxo-1h-benz(de)isoquinoline-2(3h)- acetic acid derivatives
IE58620B1 (en) N-(6-methoxy-5-(perfluoroalkyl)-1-naphtholyl)-n-methylglycines and their thionaphthoyl analogs
PL143070B1 (en) Method of obtaining novel hidantoine derivatives
US5877318A (en) Hydroquinone derivative and pharmaceutical use thereof
US4612317A (en) Tetrahydro-β-carboline dithioic acid derivatives and treatment of liver diseases
US4018798A (en) Substituted (4-oxo-4H-1-benzopyran-2-yl)cyclopropane carboxylic acids and esters
US4237132A (en) Morpholinone derivatives and method of use
JPH02193965A (ja) 新規な２―ハロゲン置換ｎ―インドリルエチル―スルホンアミド、それらの製造方法、及び薬物におけるそれらの使用
KR820001305B1 (ko) 스피로-히단토인 화합물의 제조방법
KR860001870B1 (ko) 이미다졸리딘디온 유도체의 제조방법